WPG Advisers’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
SI
DCM
RHJA
ORI
WPG Advisers's IRMD Position: Q2 2026 in Review
WPG Advisers held its iRadimed (IRMD) position steady in Q2 2026 at 89 shares worth $8.51K. The position accounts for 0.01% of the portfolio, ranked #821.
WPG Advisers first reported a position in IRMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.66K in Q4 2025. 82 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.
- WPG Advisers held 89 shares of iRadimed worth $8.51K as of Q2 2026.
- WPG Advisers left its iRadimed share count unchanged in Q2 2026.
- iRadimed made up 0.01% of WPG Advisers's portfolio in Q2 2026, its #821 holding.
- WPG Advisers first reported a position in iRadimed in Q4 2024 and has held it in 7 quarters since.
- WPG Advisers's iRadimed position peaked at $8.66K in Q4 2025.
- 82 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.
Based on WPG Advisers's 13F filing for Q2 2026, filed 6 Aug 2026.